R1NHNH2, EtOH, Et3N
N
N
N
0–5°C (for 3a)
BrCN
R
R
or PhNHNH2, MeCN
NaHCO3, 0°C (for 3b)
Et3N, Me2CO, 0–10°C
(for 2a)
or EtOAc, (for 2b)
N
H
1a,b
CN
2a,b
9
8
6
5
N
N
7
6
7
8
R1
4
N1
N2
N3
N
N
+
Ph
4
9
10
5
3
N
1
2
3a,b
H2N
H2N
(from 2а)
4 (from 2b)
2-Chloro-1-cyanobenzimidazole (2a). Et3N (2.9 ml, 2.12 g, 21 mmol) was added to a solution of azole
1a (3.05 g, 20 mmol) in absolute acetone (40 ml) cooled to 0°C, and the reaction mixture was maintained below
10°C while a solution of cyanogen bromide (2.12 g, 20 mmol) in acetone (10 ml) was added. After 20 min, the
mixture was filtered, and the filtrate was evaporated. The dry residue after evaporation was then recrystallized
from hexane. Yield 2.84 g (80%). White crystalline powder. Mp 129-130°C (decomp.). IR spectrum, , cm-1:
1
2257, 1612, 1512, 1459, 1354, 1246, 1200, 756, 744. H NMR spectrum, , ppm: 7.56-7.54 (2H, m, H-6,7);
7.51-7.49 (2H, m, H-4,5). 13C NMR spectrum, , ppm: 102.1 (CN); 109.8 (C-7); 119.8 (C-4); 123.3 (C-5); 123.5
(C-6); 133.6 (C-7a); 140.2 (C-3a); 145.3 (C-2). Found, %: C 54.02; H 2.21; N 23.59. C8H4ClN3. Calculated, %
C 54.11; H 2.27; N 23.66.
2-(Chloromethyl)-1-cyanobenzimidazole (2b). A solution of cyanogen bromide (2.12 g, 20 mmol) in
EtOAc (10 ml) was added dropwise with vigorous stirring to a refluxing solution of azole 1b (6.66 g, 40 mmol)
in EtOAc (40 ml). The reaction mixture was refluxed for a further 30 min and cooled. The precipitated crystals
of 2-(chloromethyl)benzimidazole hydrobromide were filtered off and the filtrate was evaporated on a rotary
evaporator. The dry residue after evaporation was recrystallized from a mixture of hexane and EtOAc (9:1).
Yield 2.23 g (58%). White crystalline powder. Mp 122-124°C. IR spectrum, , cm-1: 2335, 1621, 1539, 1422,
1244, 1141, 806. 1H NMR spectrum, , ppm: 4.63 (2H, s, CH2Cl); 7.32-7.04 (2Н, m, H-5,6); 7.95-7.81 (2H, m,
H-4,7). 13C NMR spectrum, , ppm: 41.2 (CH2Cl); 99.7 (CN); 112.8 (C-7); 120.5 (C-4); 123.3 (C-6); 124.0
(C-5); 133.7 (C-7a); 139.4 (C-3a); 151.9 (C-2). Found, %: C 56.33; H 3.12; N 21.89. C9H6ClN3. Calculated, %:
C 56.41; H 3.16; N 21.93.
1H-[1,2,4]Triazolo[4,3-a]benzimidazol-3-amine (3a). A mixture of Et3N (0.84 ml, 0.607 g, 6.0 mmol)
and hydrazine hydrate (0.28 ml, 0.285 g, 5.7 mmol) in EtOH (5 ml) was added with stirring to a solution of
compound 2a (0.854 g, 5.6 mmol) in EtOH (10 ml) cooled to 0-5°C. The reaction mixture was heated to room
temperature and stirred for 1 h. The solution was evaporated on a rotary evaporator. The residue was dissolved
in acetone (5 ml), and Et3N·HCl was filtered off. The acetone solution was again evaporated and the dry residue
was recrystallized from EtOH. Yield 0.756 g (78%). White crystalline powder. Mp 203-205°C. IR spectrum, ,
1
cm-1: 3214-3125, 1659, 1557, 1471, 1278, 1242, 1005, 814. H NMR spectrum, , ppm: 11.40 (1Н, br. s, NН);
7.82-7.78 (2Н, m, Н-5,8); 7.32-7.27 (2Н, m, Н-6,7); 7.06 (2Н, br. s, NН2). 13C NMR spectrum, , ppm: 110.7
(С-5); 120.9 (С-6); 121.3 (С-8); 122.7 (С-7); 128.1 (С-4a); 139.1 (С-8a); 147.5 (С-9a); 152.0 (С-3). Found, %:
C 55.51; H 4.01; N 40.48. C8H7N5. Calculated, %: C 55.49; H 4.07; N 40.44.
1-Phenyl-1H-[1,2,4]triazolo[4,3-a]benzimidazol-3-amine (3b) was obtained similarly using
phenylhydrazine instead of hydrazine hydrate. Yield 0.963 g (69%). White crystalline powder. Mp 191-192°C.
1
IR spectrum, , cm-1: 3306-3126, 1632, 1474, 1443, 1339, 1292, 1027. H NMR spectrum, , ppm: 7.94-7.87
13
(1Н, m, Н-8); 7.51-7.34 (3Н, m, H-5, H Ph); 7.31-7.05 (5H, m, H-6,7, H Ph); 6.41 (1Н, br. s, NH2). C NMR
spectrum, , ppm: 110.6 (С-5); 119.9 (С Ph); 120.8 (C-6); 121.1 (C-8); 122.6 (C-7); 129.0 (C-4a); 129.1 (C Ph);
130.3 (C Ph); 136.1 (C Ph); 139.3 (C-8a); 151.6 (C-9a); 153.9 (C-3). Found, %: C 67.49; H 4.43; N 28.16.
C14H11N5. Calculated, %: C 67.46; H 4.45; N 28.09.
1875